Results for Bronchopulmonary Dysplasia

Dr. Bamat’s research interest is neonatal respiratory failure, with an emphasis on pharmacotherapies for severe bronchopulmonary dysplasia and continuous distending airway pressure levels in infants requiring respiratory support.

Erik Jensen, MD, MSCE, is an attending neonatologist in the Division of Neonatology at Children's Hospital of Philadelphia.

Dr. DeMauro has special expertise in rigorous assessment of early childhood outcomes of high-risk neonates. Her research focuses on improving outcomes of children with bronchopulmonary dysplasia and school-age assessment of functional outcomes in preterm-born children.

Dr. McGrath-Morrow is associate chief of the Division of Pulmonary and Sleep Medicine and leader of the Post-preemie Lung Disease Clinic at Children’s Hospital of Philadelphia. Her research seeks to link early life events with adult lung health and biomarker discovery for future trials.

Dr. Sengupta is a neonatologist and physician scientist with a long-standing interest in lung health. She studies the mechanisms of circadian regulation of lung inflammation, injury, and repair; and the effect of early life exposures on development and function of pulmonary circadian networks in adulthood.

Dr. Foglia's research aims to identify the best methods to monitor and perform neonatal resuscitation, with the ultimate goal of optimizing outcomes for high risk infants who require resuscitation in the delivery room and neonatal intensive care unit setting.

Dr. Young’s translational research program aims to understand mechanisms underlying interstitial and rare lung diseases and develop new strategies to treat these disorders. Her laboratory focuses on the roles of epithelial cells in alveolar homeostasis, injury, and repair.